Abstract: Titanium dioxide (TiO 2 ) is a common additive that is increasingly used in consumer products, food, pharmaceutical dosage forms and cosmetic articles. However, due to size reduction of TiO 2 particles from the microscale to the nanoscale, application areas of this material are expanding, especially in the food sector, which makes investigations of nano-TiO 2 crucial. This review focuses on two important topics of current research regarding the oral pathway: 1) anatomy of the orogastrointestinal tract, composition of epithelial and mucus layer, and pH changes; 2) cell entry mechanisms, cytotoxicity and translocation. Sufficient knowledge on the oral uptake route is not yet available but is highly needed for human risk evaluation.
Introduction
The development of engineered nanomaterials (ENM) and their commercialization for application in (consumer) products, medical and diagnostic devices and/or pharmaceutical drug delivery vehicles presents an enormous challenge for the scientific, regulatory, industrial and public field. So far, a number of international guidelines are available. Generally, chemicals are regulated under REACH (registration, evaluation, authorization and restriction of chemicals) and pharmaceutical and medical nanoproducts are under regulation of the European Medicines Agency (EMA) and Food and Drug Administration (FDA). For the assessment of toxicological effects of ENMs (e.g., cytotoxicity, genotoxicity, carcinogenicity) several guidelines by the OECD Working Party on Manufactured Nanomaterials (WPNM) are available, taking into account existing information and scientific results. Numerous in-vitro and in-vivo tests are implemented in these guidelines and can be used for regulatory purposes [1] . Nevertheless, there are concerns dealing with dosimetry, cellular uptake, characterization, interaction with cells and visualization methods. Thus, the validated test systems need to be adapted to the respective nanomaterial and cellular uptake, characterization, interactions with cells and visualization methods need to be implemented. In 2007 the WPNM launched the Sponsorship Programme. This programme involves OECD member countries, non-member economies and stakeholders to combine expertise of several so-called priority nanomaterials, such as titanium dioxide (TiO 2 ), silicium dioxide (SiO 2 ), silver nanoparticles and others [2] . In this review we particularly focus on TiO 2 .
TiO 2 is an inorganic, inert compound that exists in three polymorphs, i.e., anatase, rutile and brookite. It is a fine white, crystalline, odorless powder that is thermally stable and nonflammable and shows poor solubility. The latter property was considered to exhibit low negative adverse effects [3] [4] [5] [6] [7] . As a bulk material TiO 2 is used as pigment and belongs to the top 50 chemicals produced worldwide. Seventy percent are utilized as pigment in paints due to the brightness and high refractive index. Furthermore, TiO 2 is used in papers, inks, pharmaceuticals, plastics and also food. The FDA established a regulation for TiO 2 as color additive for food to assure that the usage is safe [8] . By reducing the particle size from the microscale to the nanoscale, the material changes its properties. The surface to mass ratio increases, which may result in an enhanced solubility and dissolution rate, wettability, shape and cristallinity change and absorption of ultraviolet radiation or anticorrosive effects occur, just to mention some examples. These properties offer great opportunities, thus nano-TiO 2 is a versatile compound that is in daily use in cosmetics, industrial photocatalytic processes and cleaning air products. Several processes to synthesize TiO 2 nanoparticles have been developed over the last decade including liquid, solvothermal and hydrothermal processes as well as solid state processing routes (milling). However, the most efficient procedure is hydrolysis of titanium salts in acidic solution taking into account the pH to obtain a narrow size distribution [9] .
Apart from manufacturing, decrease of the particle size has been identified as a key parameter for an increased toxicity behavior. Regarding nano-TiO 2 there is still no clear understanding of the toxicological profile. Thus, evaluation of the toxic potential and of the mode of action is a necessity to perform adequate hazard/risk assessment. Since several reviews exist regarding the respiratory system as a route for nano-TiO 2 , e.g., [10] [11] [12] , in the present review we will provide a comprehensive evaluation of the current knowledge concerning the oral route. In the first part, we give an overview about the anatomy of the digestive tract, starting with the port of entry, i.e., the oral cavity which is an often neglected system, followed by the gastrointestinal (GI) tract. In the second part, cellular entering mechanisms, toxic response and toxicological effects as well as translocation of nano-TiO 2 are discussed.
The digestive tract
The oral uptake route comprises oral cavity, esophagus, stomach, small intestine (duodenum, jejunum, ileum), and large intestine (ascending, transverse, descending, and sigmoid colon) and rectum ( Figure 1 ). This route is particularly complex since changes in pH influence particle properties and presence of mucus and epithelia of different heights present barriers for absorption. Additionally, for physiologically relevant testing it is important to have an approximate idea on the levels of nanoparticles to which humans are exposed after oral ingestion [13] . This estimation is a great challenge. Models based on per capita daily intake of various foods combined with expected distributions of chemicals or biological hazards in food work less well. The content of ingredients in form of nanoparticles is generally not indicated in food, interaction with food compounds is expected and physical changes of particles in the gastrointestinal tract are likely. Concentrations of metal and metal oxide in water and soil have been reported to reach 15.2 ng/L and 1.28 µg/kg for TiO 2 [14] . The digestive tract starts at the oral cavity, follows the esophagus and passes the stomach. Acid and protease production occurs in the corpus of the stomach, while the food is stored in the antrum part prior to the transition into the small intestine, starting with the duodenum. Bile and digestion enzymes, secreted from liver and pancreas, respectively, are added to the chyme in this part. Jejunum and ileum are the part of the small intestine most important for absorption of nutrients and ascending, transverse, descending, and sigmoid colon for resorption of water and salts. The appendix could play a role in immune system but fulfills no important role in the absorption of nutrients. The digestive tract terminates with the rectum. A-D refers to barrier types as depicted in Figure 2 .
Compared to other metal and metal oxide nanoparticles intake of TiO 2 by food is relatively high: Powell et al. estimate ingestion of 5 mg TiO 2 /person/day with an unknown part of it in the nanoscale [15] . Total dietary intake only of nano-TiO 2 is estimated to be 2.5 mg/ individual/day (0.036 mg/kg for a person of 70 kg [16] ). The intake of nano-and microparticles, however, shows great variations: 0-112 mg/individual/day has been reported [17] . Metal and metal oxide nanoparticles can accumulate in plants [18] and in animals of the food chain [19] and may reach considerably higher levels in humans.
The oral cavity
The upper aero-digestive tract acts as a complex barrier and displays the first main hindrance against uncontrolled uptake of a variety of substances. Materials placed in the mouth are expected to be swallowed to transit the GI tract, however, a number of small particles and bacteria remain in the oral cavity and deposit in niches. Thus, it is likely that these small particles may enter the oral mucosa. The squamous epithelium of the oral cavity has a 4000 times greater permeability than squamous epithelium of the skin and if particles are absorbed, they directly enter the systemic circulation, bypassing liver metabolism.
The stratified squamous epithelium of the oral cavity can be divided into two types [20] : keratinized and nonkeratinized epithelium. Keratinized epithelium covers parts of masticatory mucosa, such as the hard palate and gingiva. The non-keratinized epithelium covers areas of the lining mucosa, which is present on the lips, the buccal mucosa, alveolar mucosa, soft palate, the floor of the mouth and underside the tongue. Compared with the keratinized epithelium it is thicker. The buccal mucosa represents the largest surface area in the oral cavity (23% of the total surface of the oral mucosa including the tongue) [20] [21] [22] and is approximately 500-800 µm thick. It consists of mucus, the stratum-superficiale, -spinosum, and -basale. Below the basal lamina the lamina propria, a network of blood vessels, capillaries and smooth muscles can be found. If particles are able to permeate the entire tissue, they reach the systemic circulation and are distributed within the human body. The main function of the buccal mucosa, however, is the protection of the underlying tissue [23] . Thus, several barrier mechanisms are integrated in this tissue. The first decisive player in the oral pathway is the saliva, produced by the sublingual and by the salivary glands. The saliva mostly consists of water (95%-99% per weight), inorganic salts, enzymes and glycoproteins, also referred as mucins. MG1, a high molecular weight mucin in the saliva, is capable of binding to the surface of the oral mucosa and forms the mucus layer that covers the epithelium [24, 25] . The superficial layers of the epithelium act as the second barrier to the passage of materials. Due to the fact that the cells increase in size and become flatter as they get from the basal layers to the superficial layers, the main penetration barrier lies in the top third region of the epithelium [26] . The third permeability barrier is the intracellular material, derived from membrane coating granules (MCG) in the 200 µm outermost part of the superficial layer [27, 28] . These granules are small structures that produce "lipid contents" during differentiation and discharge them into intercellular spaces. Thereby they constitute a permeability barrier and thus, limit the penetration of non-polar systems. Immune cells, such as Langerhans cells and intraepithelial lymphocytes are embedded in the keratinocytes layer. While the epithelium of the oral cavity is much thicker than that of the small and large intestine, the thickness of the mucus gel layer is considerably thinner than in other parts of the GI tract. Particularly, the lack of the firmly adherent mucus gel layer could cause pronounced differences in the absorption properties between the oral cavity and the rest of the GI tract.
In recent work we demonstrated that polystyrene nano particles are able to penetrate into the buccal mucosa [29] . If they are dispersed in saliva, they increase in size due to agglomeration and interactions with mucoglycoproteins. However, the increase is higher for smaller particles (from 25 nm up to 469 nm) compared to larger particles (from 200 nm up to 373 nm). Twenty nanometer carboxyl polystyrene particles penetrated into the stratum superficiale of the top third region of the epithelium via the transcellular route. The positively charged 200 nm amino modified polystyrene particles penetrated into deeper regions of the tissue. By decreasing the temperature to 4°C, particle uptake was inhibited for both. This indicates that the penetration into the tissue is due to endocytotic mechanisms. However, the larger negatively charged 200 nm particles formed agglomerates and did not pene trate into the stratum superficiale. Thus, the mucus layer together with the top third region of the epithelium forms a strong barrier for the negatively charged particles. Additional studies by our group showed that uncharged parti cles (similar to spherical viruses, like the Norwalk and human papilloma virus) permeated the mucus layer and penetrated the epithelium of the buccal mucosa [30] . The permeation through the mucus layer, however, was size dependent. 200 nm particles, with a slightly negative ζ potential (-17.3 mV) were able to overcome the mucus layer more efficiently and penetrated into the top half part of the epithelium to a higher extent. This indicates that the uptake was markedly better for larger particles than for 50 nm and 25 nm particles. This size dependent uptake of nanoparticles in the buccal mucosa is attributed to the anatomical and biophysical structure of the mucosa. First of all, mucus alters the mobility of smaller particles to a higher extent compared to larger ones. Additionally, the morphology of the epithelium displays ridge like folds, so-called microplicae that determine the internalization of nanoparticles. It seems that an optimal particle size is mandatory for the uptake process and that the driving forces, energy input and electrostatic repulsion forces are of significant importance in this process. Concerning the buccal uptake behaviour, nano-TiO 2 has not been investigated so far. However, P25 (Aeroxide, Evonik Degussa GmbH, Essen, Germany) nano-TiO 2 is the reference material of the OECD and has been used in many mammalian studies [31] [32] [33] [34] [35] . The average particle size of P25 is 21 nm (determination via electron microscopy) with a specific surface area of 50 ± 15 m 2 . The crystal structure is a mixture of 70%-85% rutile and 15%-30% anatase. The dispersion status of nanoparticles in aqueous media generally depends on the surface properties of the given nanoparticle. P25 particles show hydrophilic surface properties, thus it is expected that the particles tend to agglomerate when dispersed in water. The mean particle size in pure water, measured by dynamic light scattering, was 160 ± 5 nm in pure water [32] and buffered with tetrasodium pyrophosphate (pH 4.8) 140 ± 44 nm [35] . At pH 7.5 the ζ potential value, measured in culture medium was slightly negative (-11.6 ± 1.2 mV) [36] . Based on the similarity of these parameters to those of the 200 nm amino modified polystyrene particles, we hypothesize that P25 particles could be able to penetrate/permeate the buccal mucosa.
GI tract
The epithelium of the stomach shows a heterogeneous composition, consisting of mucus neck cells, pepsinogen-producing gastric chief cells, gastric acid and intrinsic factor producing parietal cells and a variety of hormones (gastrin, serotonin, somatostatin, etc.) producing enteroendocrine cells. Secretion of hydrogen carbonate (amounting to 2%-10% of maximum H + secretion) in conjunction with the adherent mucus gel layer (functioning as a mixing barrier) protects gastric mucosa from luminal acid by a process of surface neutralization. Such a prominent firmly adherent mucus gel layer, in addition to the loosely attached one, can be seen in the antrum of the stomach and in the large intestine (Figure 2) . The extracellular lining of the mucus in the stomach consists of zwitterionic phospholipids that lead to the binding preference of lipophilic molecules. The protection of the epithelium by a thick mucus gel layer also hinders the uptake of macromolecules from the food. It is unlikely that appreciable amounts of particles can be absorbed through the stomach. The mucus gel layer, in general, plays a greater role for the absorption of macromolecules and particles in the parts following the oral cavity. Gastrointestinal mucus consists mainly of Muc2 protein, a protein synthesized mainly in goblet cells, and consisting of cysteine-rich N-and C-terminal parts and a central serine, threonine, and proline-rich region. O-glycosylation takes place at the amino acids of the central part and crosslinking at the N-terminal parts via disulfide formation. Large polymers, stored in mucin granulae, are secreted and form the firmly adherent mucus gel layer. The firmly adherent mucus gel layer consists of densely packed Muc2 and appears stratified. The loosely adherent layer originates from this layer by partial Figure 2 Barrier types in the digestive tract. In the oral cavity and the esophagus a thick squamous epithelium with a relatively thin loosely adherent mucus gel layer is seen (A). At other regions of the GI tract, a firmly adherent (fm) and a loosely adherent (lm) mucous cell layer can be discerned. The epithelium of the stomach is relatively thin in comparison to the covering mucus layer (B). The thickness of the firmly adherent mucus gel layer increases from corpus to antrum of the stomach. Folds in the gastric mucosa (rugae) allow expansion of the stomach upon meal intake. Epithelium and mucus gel layer are thin in the small intestine, particularly in the jejunum, where absorption takes place (C). In these parts, the area for absorption is enlarged by the formation of numerous folds and crypts. Mucus gel layer, both the firmly adherent portion and the loosely adherent one, reaches its maximum thickness in the colon (D). In the colon, only crypts, where mucus production takes place, are seen.
proteolysis of the disulfide bonds leading to expansion of the gel and formation of a network [37] . The anionic charge and the hydrophobicity of the fibers in combination with the mesh size of the net determine the passage of macromolecules and particles. In general, positively charged and hydrophobic particles are retained to greater extent than neutral or cationic hydrophilic particles [38] . The intestinal epithelium is composed of cells belonging to the immune system (M-cells), enteroendocrine cells and goblet cells are embedded in a layer of enterocytes. Scattered throughout the mucosa, the organized mucosa associated lymphoid tissues (O-MALT) is found, which comprises lymphoid follicles [39] . These follicles form structures, such as Peyer's patches and are separated from the lumen by the follicle associated epithelium (FAE). This FAE contains so-called M-cells, which are mostly located in the overlying epithelium of Peyer's patches. They represent an important entry for oral delivery of particulate systems [40] . They have a high transcytotic capacity and can transport nanoparticles. However, the mechanisms behind are still not clearly understood as well as the role of M-cells in the immune response of the intestinal mucosa. Epithelial cells are linked together by intercellular junctions, which are responsible for the mechanical strength and limit passage between the cells. The mucus layer, which is produced by goblet cells, consists of a small firmly attached portion and a loosely attached layer with variable thickness (Figure 2) . It is debated if the mucus layer is continuous or shows mucus-free areas in the small intestine. The epithelium in the large intestine consists of enterocytes and goblet cells, and rare enteroendocrine cells. Mucus gel layer thickness increases from the proximal to distal parts [41] and varies between 730 and 1136 µm (taking into account shear forces and bacteria) in the colon [42] .
Uptake of nanoparticles from the gastrointestinal tract depends on size and surface properties. Studies by Desai et al. [43, 44] revealed that in Caco-2 cells as well as in rat gastrointestinal epithelium, nanoparticles in a size of 100 nm showed higher cellular uptake/ penetration compared to sizes from 500 nm to 10 µm. Additionally, it has been demonstrated that the surface charge also impacts the penetration/permeation into/through the mucosa. Positively charged nanoparticles with a ζ potential from +15 to +30 mV showed an efficient uptake by enterocytes compared to negatively charged nanoparticles, where uptake was significantly decreased [45, 46] . Koenemann et al. [47] investigated nano-TiO 2 particles in sizes < 40 nm. The particles showed high aggregation tendency. In nanopure water they revealed sizes of 220 nm and in cell culture medium they measured up to 500 nm. ζ potential values were a function of the pH. In acidic media, the values were +10 mV for nanopure water and approximately + 33 mV in cell medium. With increasing pH, ζ potential values decreased. At pH 7 negative values were obtained. From these data one would expect that the nano-TiO 2 particles only reveal minor cell uptake/penetration. Interestingly, nano-TiO 2 was able to cross the epithelial lining without disrupting cell junctions. However, more investigations in this field are needed.
Cellular entering mechanisms/toxic response in epithelial tissues
There are at least three pathways, how nanomaterials can cross the epithelium [47] : first, they can disrupt the cell junctions (i.e., paracellular route), second they can be internalized by the cells through different pathways (i.e., transcellular route, e.g., macropinocytosis, endocytosis) and finally, they can have a toxic effect on the cells or alter cell function, resulting in cell death.
The key mode of nano-TiO 2 uptake, however, is displayed by transcytotic pathways. Thereby, particles are most likely uptaken by endocytotic mechanisms and transported via vesicular structures [48, 49] . Major mechanisms are phagocytosis, macropinocytosis, clathrinmediated endocytosis, caveolae-mediated endocytosis and clathrin-/caveolae-independent endocytosis. An overview of in-vitro data is provided in Table 1 . Koeneman et al. [47] investigated possible pathways by which TiO 2 nanoparticles (mean particle size 40 nm, mixture of rutile and anatase) could cross the intestinal epithelium. Therefore, they used human colon carcinoma Caco-2 cells, a cell line which forms a monolayer with tight intercellular junctions and apical brush border. These results showed that nano-TiO 2 particles aggregated in the cell culture medium to a high extent ( > 500 nm) and did not affect/disrupt junctional complexes of the intestinal epithelium; hence, Table 1 In vitro studies of nano-TiO 2 uptake in intestinal cell systems.
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Crystal No cytotoxic effects; Intact epithelium paracellular uptake could be neglected. Additionally, after acute and chronic exposure of nano-TiO 2 , cell viability of intestinal epithelial cells was not impacted at applied concentrations ranging from 1 µg/mL to 10 µg /mL. Thus, it can be hypothesized that nano-TiO 2 particles enter intestinal cells by transcytosis without affecting the membrane integrity. Particle entry caused disruption of the microvillar organization due to increased intracellular free calcium levels. These suggestions were partially confirmed by Burn et al. [52] . In their studies they tested 95% anatase and 100% rutile TiO 2 nanoparticles with mean diameters of 12 nm and 21 nm, respectively. Particles aggregated, once dispersed in cell culture medium and the hydrodynamic diameters, evaluated by photon correlation spectroscopy, were greater than 1 μm. Cell viability and transepithelial electrical resistance remained high at 24 h exposure (investigated concentrations from 1 to 100 μg/mL). Inside the cells, clusters of particles (1-2 μm) were detected in intracytoplasmic vesicles or endosomes. Thus, the authors concluded that due to their large size, agglomerates of the particles would rather be internalized through macropinocytosis, the major pathway for particles around 1 μm, even if no characteristic membrane ruffling was observed. Comparing the enterocyte uptake mechanisms of nano-TiO 2 with that of other epithelial cells, like prostate cancer cells [53] , similar observations were described. Upon energy depletion and use of specific uptake inhibitors, uptake of nano-TiO 2 mainly by macropinocytosis and clathrin-mediated endocytosis was suggested. Surprisingly, some other studies report that after nano-TiO 2 uptake, particles were found freely distributed in the cytoplasm, the mitochondria and in the nucleus [54, 55] . This indicates that apart from endocytosis other routes of cellular entry are possible. After inhalation of nano-TiO 2 , for instance, particles were observed in red blood cells [56] . Thus, signal-mediated diffusion through membrane pores, and/or passive transport triggered by electrostatic, Van der Waals or steric interactions (subsumed as adhesive interactions) may also occur. Size is a key parameter in nanotoxicology. Gerloff et al. [50] investigated three different types of TiO 2 particles, fine pure anatase (40-300 nm), ultrafine 80% anatase, 20% rutile (P25, 20-80 nm) and ultrafine anatase modified ( < 10 nm) in a Caco-2 cell line. The results revealed that after 24 h incubation (applied concentrations 20 and 80 µg/cm 2 ) LDH release was induced on Caco-2 cells at highest concentration, resulting in loss of membrane integrity. Furthermore, the metabolic activity was reduced dose-dependently. Additional work by Geldoff et al. [51] showed that cristallinity (i.e., anatase-rutile, anatase) and specific surface area impact the cytotoxicity of nano-TiO 2 .
Only samples comprising anatase and rutile induced significant LDH leakage. Interestingly, the metabolic activity depended on both, the specific surface area and the crystallinity of the material. The anatase-rutile samples revealed a higher toxicity per unit surface area than pure anatase powders. However, future studies are needed, to carefully address the mechanisms and clarify the role of nano-TiO 2 (taking into account the properties) in the toxic response in orogastrointestinal epithelial cells.
Main mechanisms of TiO 2 -induced cytotoxicity
The clear understanding of the uptake mechanisms and the localization of particles within cellular compartments are essential to assess potential biological hazard. Cytotoxicity of TiO 2 nanoparticles has been reported in a variety of cell types [57] [58] [59] [60] [61] . The action of nanoparticles is often linked to generation of reactive oxygen species (ROS) and depletion of cellular antioxidants. A dysbalance between the level of ROS and antioxidants within the cells leads to oxidative damage with oxidation of proteins, lipids and DNA [62] . It could already be demonstrated that nano-TiO 2 has the potential to generate ROS and oxidative stress [36, 63, 64] , which may result in inflammation and mitochondriamediated cell death [59] . Non membrane-bound, freely distributed particles are easily available for interaction with intracellular proteins, organelles and DNA, which can amplify their toxic potential. If these particles deposit in mitochondria, they can damage mitochondrial function by enhancing ROS production [65] . Furthermore, previous studies demonstrated that nano-TiO 2 and other metal oxide particles penetrated into cell nuclei, which may imply a direct interference with the structure and function of genomic DNA [12, 54, 66] . Thus, the question of harmful DNA alterations and genotoxic effects arises. The mechanisms of nanoparticle-induced DNA disruption can be divided into the primary and secondary genotoxicity [67] . When particles are taken up by the cells, they can induce primary genotoxic effects directly via DNA interactions or indirectly via ROS production, whereas secondary genotoxicity can be triggered by a chronic inflammatory response. An indication for direct genotoxic mechanisms for nanoTiO 2 was reported by Li and Zhu, who demonstrated a chemical interaction between nano-TiO 2 and DNA phosphate groups [68, 69] . However, most studies suggest indirect damage of DNA by nano-TiO 2 via intracellular generation of ROS [31, 32, 70, 71] and/or inflammatory response [72] [73] [74] [75] . Oxidative DNA lesion can lead to single-strand breaks after Translocation from the oral route/ toxic effects of nano-TiO 2 in vivo Nano-TiO 2 may also enter systemic circulation, when particles overcome the epithelial barrier and infiltrate organs (overview of in vivo data provided in Table 2 ). Recently, it has been demonstrated that particles can accumulate after oral administration [85, 86] in liver, spleen, lung and kidney. Thereby, different toxic effects such as hepatocyte injury and renal lesion and elevations of alanine aminotransferase (ALT) and blood urea nitrogen (BUN) became apparent [35, 85] . Further investigations showed that hepatocyte apoptosis and damage of the liver functions were caused by ROS production [81, 82] . Affection of liver and kidney seems reasonably since orally applied substances are usually absorbed in the small intestine and reach the liver as first organ. Kidney damage may be caused by obstruction of the renal filter by nanoparticles. Additionally, the deposition of nano-TiO 2 within the liver is also associated with an impaired haemostasis and a decreased immune response [81] . Histopathological changes were also observed in spleen tissue, including congestion and lymph nodule proliferation. Furthermore, it was suggested that nano-TiO 2 induced ROS facilitated inflammation, leading to strong lipid peroxidation. Adverse effects due to translocation were also induced in organs such as heart, blood and bone marrow [34, 85] .
Different biomarkers are often used to estimate potential cardiovascular damage, such as lactate dehydrogenase (LDH) combined with creatine kinase. In case of TiO 2 particles, different studies revealed an increased LDH level in serum, which is an indication of myocardial tissue alterations and lesion [86] [87] [88] . Bu et al. confirmed these results and showed that mitochondrial swelling in heart tissue occurs after oral application of nano-TiO 2 [80] . Genotoxic damage, namely oxidative DNA damage, DNA single and double-strand breaks and micronuclei formation, were detected in the study performed by Trouiller at al. [34] . It remains unclear why the very high concentrations of 5 mg/kg used in the studies of Warheit et al. and Wang et al. [35, 86] caused smaller effects than the much lower doses used in the other studies. Agglomeration occurring at high concentrations could explain the observed discrepancy. It is currently unclear, whether nano-TiO 2 particles can permeate through the buccal epithelium and can reach the systemic circulation bypassing the liver.
Conclusions
Nanoparticle size, surface reactivity, hydrophilicity/ hydrophobicity and type of crystallinity have been identified as key parameters for an increased toxicity behavior with biological tissues. Regarding nano-TiO 2 there is still no clear understanding of the toxicological profile. However, evaluation of the toxic potential and of the mode of action is a necessity to perform adequate hazard/risk assessment. The most affected organ regarding TiO 2 uptake is the respiratory tract followed by the skin. Regarding other organs, such as the oro-gastrointestinal tract, data are limited and thus, assessment of potential risks of TiO 2 is difficult. However, studies reveal that the key-mode of TiO 2 is displayed by transcytotic pathways and that the main mechanisms initiated are dominated by inflammation-driven effects, such as oxidative stress and DNA damage. If TiO 2 particles enter systemic circulation, they translocate in different organs, including liver, spleen, lung, kidney and even heart and induce adverse effects. Since nanoparticles are small enough to overcome the obstacles in the oral cavity and in the intestinal mucosa, it is expected that nano-TiO 2 particles may either enter directly the systemic circulation (bypassing the liver) or are swallowed and may accumulate in the liver via permeation of the mucosa of the small intestine.
